NUDT15 gene study for Taiwanese IBD patients
Part of Blood & lymphatic, Digestive system clinical trials.
This study looks at how certain gene changes (NUDT15) affect people with inflammatory bowel disease (IBD) in Taiwan. It aims to help doctors better understand and treat IBD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with inflammatory bowel disease (IBD).
- You are willing to have a blood test to check your NUDT15 gene.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes of people with inflammatory bowel disease (IBD) and healthy volunteers to understand why IBD affects different populations. You may join if you have Crohn's disease, ulcerative colitis, or undetermined IBD, or if you are a healthy person without any IBD history.
This study looks at how certain natural chemicals called polyamines relate to the activity of inflammatory bowel disease (IBD). It aims to understand if these chemicals can help predict disease progression.
This study looks at people with active Crohn's disease or ulcerative colitis starting a new type of medication (anti-TNF, ustekinumab, upadacitinib, or vedolizumab), as well as people without IBD having a routine colonoscopy. It aims to collect information to better understand how these treatments work.
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
This study collects samples to learn how gut microbes, genetics, and body chemistry may relate to Crohn’s disease or ulcerative colitis. Your information and samples may help researchers understand disease patterns, but it does not test a new drug.
This study tests a new care program designed to help people with inflammatory bowel disease (IBD) manage their condition better and improve their quality of life. If you join, you'll receive extra support and training to help you cope with your symptoms and daily life.
Hear when a new Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.